Guardant Health (@guardanthealth) 's Twitter Profile
Guardant Health

@guardanthealth

Conquering Cancer With Data

ID: 618500573

linkhttp://www.guardanthealth.com calendar_today25-06-2012 22:41:23

1,1K Tweet

6,6K Followers

758 Following

Guardant Health (@guardanthealth) 's Twitter Profile Photo
Guardant Health
@guardanthealth

a year ago

The new guidelines indicate that blood-based ctDNA testing is preferred due to greater sensitivity. Guardant360® CDx test is the only FDA-approved CDx to identify patients with ESR1 mutations who may benefit from treatment with ORSERDU™ (elacestrant). bit.ly/3Jm8r5l